We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Developing a New Modality Using Targeted Therapeutic Discovery
Whitepaper

Developing a New Modality Using Targeted Therapeutic Discovery

Developing a New Modality Using Targeted Therapeutic Discovery
Whitepaper

Developing a New Modality Using Targeted Therapeutic Discovery

For several years one of the hottest fields for academic research and industrial development has been the human microbiome. The microbes comprising an individual’s microbiome can be pathogenic or live in symbiosis with the human body. Due to the sheer masses of bacteria found on and inside of the body and the amount of research needed to study them, adequate software must be applied to store the huge amount of data generated.

Download this case study to find out how Vedanta Biosciences, Inc. utilized Thermo Scientific Core LIMS™ and Core ELN™ software to:


  • Support efforts to develop the human microbiome into a new modality for drug development
  • Track many aspects of the company’s bacterial library
  • Produce a reservoir of data to support further downstream development
Advertisement